What is actually happening in Health?

How Many Cancer Patients Survive One Year?

One-year cancer survival in England has risen from 59.8% in 2001 to 73.7% in 2023 — a significant improvement driven by better treatments and faster diagnostic pathways. But a quarter of cancers are still diagnosed late, and the UK consistently ranks in the bottom third of comparable European nations for cancer survival.

In 2001, fewer than six in ten adults diagnosed with cancer in England survived a full year. By 2023, that figure had climbed to 73.7%.[1] The gains have been uneven across cancer types: breast and prostate one-year survival now exceeds 95%, while lung cancer — still the biggest killer — has seen its one-year survival rise from under 30% to 44.6%, the steepest absolute improvement of any major cancer.[1] Immunotherapy and targeted treatments introduced since 2016 have been a key driver of that shift.

Yet the story is complicated by persistent weaknesses in early detection. Nearly a quarter of all cancers are still diagnosed at stage 3 or 4, when treatment options narrow and survival rates drop sharply.[3] The pandemic made things worse: screening programmes were paused for months in 2020, and the resulting diagnostic backlog pushed late-stage diagnoses up to 26.8% that year.[3] Screening uptake has since recovered but remains below pre-pandemic levels for breast and cervical programmes.[2] International comparisons remain uncomfortable — the UK consistently ranks in the bottom third of comparable European countries for one-year cancer survival, behind Denmark, the Netherlands, Norway, and Australia. The gap is not explained by treatment quality but by how late cancer is found.

One-year cancer survival rate, England, 2001–2023

Proportion of adults surviving at least one year after cancer diagnosis. Age-standardised. Steady improvement interrupted by COVID-19 diagnostic disruption in 2020.

Source: Office for National Statistics, Cancer survival in England — adults diagnosed, 2023, Updated annual

Cancer screening uptake by programme, England, 2010–2023

Percentage of eligible population screened. Bowel uptake rising since FIT test introduction; breast and cervical both below 80% target and below pre-pandemic levels.

Breast screening (%)
Bowel screening (%)
Cervical screening (%)

Source: NHS Digital, Cancer screening programme statistics, 2023, Updated annual

Lung cancer survival improving fastest of any major cancer type

+6.1ppone-year survival in 5 years

Lung cancer one-year survival has risen from 38.5% to 44.6% in just five years — the fastest improvement of any major cancer type. This reflects immunotherapy and targeted treatments on the NHS, and early results from the Targeted Lung Health Check programme, which detects 80% of lung cancers at early stages in pilot areas compared to 27% through the standard symptomatic pathway. Rolling out nationally by 2027 could prevent an estimated 12,000 lung cancer deaths over its first decade.

Source: ONS — Cancer survival in England 2023. NHS England — Targeted Lung Health Check interim evaluation 2025.

  1. [1]ONSCancer survival in England — adults diagnosed, 2023
  2. [2]NHS DigitalCancer screening programme statistics, 2023
  3. [3]NHS EnglandCancer Waiting Times and staging data, March 2026

Sources & Methodology

ONS — Cancer survival in England — age-standardised net survival estimates. Updated annually. Retrieved March 2026.

NHS Digital — Cancer screening programme statistics — uptake by programme. Retrieved March 2026.

NHS England — Cancer Waiting Times and staging data — late-stage diagnosis rates. Retrieved March 2026.

COVID-19 caused major diagnostic disruption in 2020; fewer cancers were diagnosed and those found tended to be more advanced, temporarily affecting survival figures. Staging completeness has improved over time, so apparent increases in late-stage diagnosis may partly reflect better recording. Data covers England only.

More in NHS & Healthcare